
Healthcare firm Alliance Pharma has backed a sweetened £362 million takeover offer by its largest shareholder and activist investor DBay Advisors.
The deal – the sixth by DBay – will see shareholders get 64.75p a share, up from the original offer worth 62.5p a share, or £349.7 million.